Links Between Phthalates and Diabetes/Obesity
Over 600 peer-reviewed studies published since 2006 in scientific journals have examined the relationship between phthalates and diabetes or obesity.
The majority of human epidemiological studies have found that people with higher exposures to phthalates have a higher risk of type 2 diabetes or obesity. This evidence includes long-term, longitudinal studies that follow people over time. The evidence linking phthalates to type 1 or gestational diabetes is preliminary to non-existent.
Exposure to phthalates in the womb or during early life-- key periods of susceptibility-- may affect the risk of developing diabetes or obesity later in life. Infants cannot metabolize or eliminate phthalates as well as adults can (Liu et al. 2020).
Laboratory studies on animals or cells show that phthalates exposures can cause biological effects related to diabetes/obesity, and have helped to identify the key periods of susceptibility and the mechanisms involved.
Studies have also found links between phthalates exposure and the risk of diabetes complications.
An expert panel of scientists determined that in the European Union, phthalate exposure has a 40 - 69% probability of causing 53,900 cases of obesity in older women with €15.6 billion in associated costs. Phthalate exposure was also found to have a 40 - 69% probability of causing 20,500 new-onset cases of diabetes in older women with €607 million in associated costs (Legler et al. 2015). In China, exposure to phthalates is estimated to be associated with ~2.50 million cases of infertility, obesity, and diabetes in 2010, causing ~57.2 billion Chinese Yuan (equivalent to ~9 billion U.S. dollars) of health care costs in a year (Cao et al. 2019).
Phthalates, chemicals often used as plasticizers, are present in a large variety of consumer products, including PVC. There are various types, and each type has various metabolites (usually the metabolites start with "M" -- e.g., MEHP is a metabolite of DEHP. Low molecular weight phthalates are being replaced by high molecular weight phthalates.
Reviews of Phthalates and Diabetes/Obesity
A review finds that laboratory and human studies show that phthalates and other food contaminants have a role in the development and progression of diabetes (Milanović et al. 2023).
A review finds that human studies show that exposure to phthalates (and bisphenols) is associated with an increased risk of diabetes. Animal studies show that treatment with doses within the range of human exposure decrease insulin sensitivity and glucose tolerance, and affect beta cell mass and insulin levels (Martinez-Pinna et al. 2023).
A review of the evidence between phthalates and type 1, type 2, and gestational diabetes, and finds potential links (Mariana and Cairrao, 2023).
A systematic review and meta-analysis finds that Exposure to phthalates were associated with an increased risk of metabolic syndrome (Mérida et al. 2023).
A meta-analysis of human studies found that exposure to phthalates (and PFAS, PCBs, and PBDEs) increase the risk of gestational diabetes, and experimental studies highlight potential mechanisms (Yao et al. 2023).
A review and meta-analysis found that exposure to the phthalates MnBP, MBzP, MCPP, MEHP, MEOHP, MEHHP, the sum of DEHP pthalates (∑DEHP), and the sum of high-molecular weight phthalates (∑HMWP) was associated with increased insulin resistance (Gao et al. 2021).
A review found that exposure to phthalates, especially MMP, MnBP, MiBP, MCPP and DEHP metabolites, might be a risk factor for diabetes (Zhang et al. 2021).
A review of prenatal exposure to phthalates and obesity in childhood found that prenatal exposure to MEP appeared to be positively associated with several obesity markers, but associations for other phthalates were less clear (Gao et al. 2022).
A review of the human evidence of six phthalates and their metabolic effects found that for DEHP, studies of insulin resistance and diabetes were consistent, with a dose-response effect. For DBP and DIBP exposure, there are strong positive associations with diabetes and insulin resistance as well. For other phthalates, the evidence was slim to unstudied. The authors conclude, "the available evidence does indicate an association between exposure to these phthalates and insulin resistance, but the small number of studies and the lack of coherence with diabetes decreases confidence." (Radke et al. 2019).
A review of phthalates in obesity concludes, "Many in vitro studies indicate that phthalates are likely obesogens, promoting obesity via several mechanisms, including activation of PPARs, antithyroid effects, and epigenetic modulation. The fetal period appears to be a critical window for exposure, and differential effects are observed depending on the dose of phthalates received and gender. Recent human studies have examined the possible effects of phthalate exposure on the development of obesity, although most of them are cross-sectional and short-term prospective studies. Although the random concentrations of phthalate metabolites have good reproducibility, large-scaled longitudinal study including measures at different life ages is needed to establish the impact of phthalate exposure on the obesity epidemic" (Kim and Park, 2014).
Another review finds that "Most data support the effects of ... some phthalates, such as di-2-ethyl-hexyl phthalate, diethyl phthalate, dibuthyl phthalate, dimethyl phthalate, dibenzyl phthalate, diisononyl phthalate and others on the development obesity and type 2 diabetes mellitus. These endocrine disrupting chemicals interfere with different cell signaling pathways involved in weight and glucose homeostasis." (Stojanoska et al. 2017).
A systematic review and meta-analysis of 8 studies found a positive association between exposure to phthalate metabolites and increased insulin resistance, even after adjusting the analysis for multiple other variables (Shoshtari-Yeganeh et al. 2019). A systematic review and meta-analysis of 29 studies found a positive association between phthalate exposure and obesity, especially in adults, although findings were not always statistically significant (Ribeiro et al. 2019).
A systematic review and meta-analysis of 35 studies found significant associations between the concentrations of phthalates and their metabolites with BMI, waist circumference, and LDL cholesterol, triglyceride, and glucose levels in children and adolescents (Golestanzadeh et al. 2019).
There are more reviews as well (e.g., Biemann et al. 2021).
Type 2 Diabetes, Insulin Resistance, and Body Weight
Longitudinal Studies in Adults
The strongest evidence for the ability for environmental exposures to contribute to the development of diabetes comes from longitudinal studies. These are studies that take place over a period of time, where the exposure is measured before the disease develops.
The first longitudinal study of phthalates and type 2 diabetes published used data from the U.S. Nurses Health Studies 1 and 2. In the Nurses Health Study 1, which includes older women (average age 66), total phthalate levels were not associated with type 2 diabetes. However, in the Nurses Health Study 2, which includes middle-aged women (average age 46), total phthalate levels were associated with type 2 diabetes. Thus, phthalate exposures may be associated with the risk of type 2 diabetes among middle-aged women, but not older women. These findings may be due to menopausal status. While the younger women had higher levels of phthalates than the older women, these differences did not explain the findings. Note that this paper also found similar results for BPA exposure levels (Sun et al. 2014).
A similar study by many of the same authors, also based on the Nurses Health Studies, found that women (without diabetes) with the highest levels of some phthalate (and BPA) exposures gained more weight during the 10 year follow-up period than those with lower levels of exposures (Song et al. 2014).
Among post-menopausal women in the U.S. Women's Health Initiative, levels of various phthalate metabolites were associated with obesity and weight gain over 3 years, but not over 6 years (Díaz Santana et al. 2019). Using DXA scans, phthalates were associated with more visceral adipose tissue three years later as well (Vieyra et al. 2023). In the U.S. Women's Health Study, there were associations between some phthalates and one-year BMI change in women who transitioned from peri-to post-menopause from baseline to first follow-up (Haggerty et al. 2020).
In the U.S. Study of Women's Health Across the Nation (SWAN), phthalate metabolites were associated with more rapid body fat gain in midlife women (Peng et al. 2022). Also in SWAN, among White women, higher concentrations of numerous phthalates were associated with increased diabetes incidence over 6 years. Phthalates were not associated with diabetes incidence in Black or Asian women (Peng et al. 2023).
In elderly Swedes, levels of 42 contaminants were measured, and then diabetes incidence followed for 15 years. Nine contaminants, including the phthalate MiBP, improved the model predicting incident diabetes in the first 5 years of follow-up (Lind et al. 2022).
In Mexican mid-life women, phthalate levels were linked to higher triglyceride levels but lower blood sugar levels after 9 years (Zamora et al. 2021).
A prospective study from the Netherlands found that people with higher phthalate levels lost less weight on a diet than those with lower levels, and had a higher waist circumference and body fat percentage (van der Meer et al. 2020).
Elderly Korean adults with higher urinary phthalate metabolite levels (from DEHP) had increased insulin resistance, especially women and those with diabetes. A marker of oxidative stress was also higher in those with higher insulin resistance and phthalate levels (Kim et al. 2013). In elderly Swedish women (not men), the phthalate MiBP was related to increased abdominal body fat two years later (Lind et al. 2012).
In China, higher levels of various phthalates, especially MEHP, measured repeatedly, were associated with lower total and LDL cholesterol levels in adults (Zhu et al. 2019).
How Are We Exposed to Phthalates?
Cosmetics are a major source phthalate expsosure, and thus women have higher exposure levels than men. DEHP is the most commonly used phthalate, used to make food packaging and medical devices (Feige et al. 2007).
Blacks, Mexican Americans, and women living in poverty are exposed to the highest levels of phthalates in the U.S. (James-Todd et al. 2012).
Teenagers who use personal care products like make-up have higher levels of many phthalates (Berger et al. 2018), and have been able to reduce their phthalate levels by choosing phthalate-free products (Harley et al. 2016). Teens who ate a diet of fresh/unprocessed food also lowered their phthalate levels (Correia-Sá et al. 2018).
Longitudinal Studies in Children
In New York City children, certain phthalate exposures measured at age 6-8 were associated with a higher body mass index and waist circumference one year later (Teitelbaum et al. 2012). In Italian adolescents, changes in DEHP metabolite levels were associated with obesity and insulin resistance. Also, the more MEHP was metabolized, the greater the insulin resistance (Smerieri et al. 2015). In other words, the body's ability to metabolize phthalates may be important. This is similar to another study from Korea, which also found phthalate metabolite levels associated with obesity and insulin resistance in girls, although this time the MEHHP metabolite (Kim et al. 2018).
Also in Korea, various phthalate metabolites were associated with increased triglyceride and insulin resistance levels in children (Han et al. 2019). In Korea, exposure to phthalates during childhood led to higher liver enzyme levels in adolescence; higher liver enzyme levels are linked to the development of metabolic syndrome (Lee et al. 2023).
In U.S. children, levels of some phthalate replacement metabolites were associated with changes in body composition through early adolescence, e.g., detectable (vs. non-detectable) MEHHTP was associated with less bone and greater fat in males, and greater bone and lean mass in females (Rokoff et al. 2023).
In 2011, it was discovered that in Taiwan, DEHP phthalate had been added to food illegally as an emulsifier. A study of some children exposed to high levels of DEHP showed that these children had lower body weight, height, and growth hormones (Tsai et al. 2016). Thus high levels of exposure may impede growth, but low levels (more normally encountered) may promote growth.
European children with higher levels of MBP have lower systolic blood pressure (Warembourg et al. 2019).
In Dutch children, DNOP metabolites were associated with overweight and an adverse cardiovascular profile (higher blood pressure and triglycerides, and lower HDL cholesterol) in children aged 6-10 (Silva et al. 2021).
In Sweden, DiNP metabolite exposure levels during preschool age were associated with subsequent development of overweight/obesity up to age 24 (Zettergren et al. 2020).
In Canadian preschool aged children, higher DnBP levels were linked higher BMI (Ashley-Martin et al. 2021).
Children in China are extensively exposed to phthalates, and exposure during childhood was associated with an increased risk of overweight and obesity with a dose-response relationship, particularly in girls (Dong et al. 2021). The same study also found that exposure to numerous phthalate during childhood was associated with significantly higher levels of triglycerides and a higher risk of dyslipidemia, particularly in boys (Gao et al. 2021).
Exposure During Development
Evidence is growing that exposure to pollution during critical developmental periods, such as in utero or during childhood, may have effects later in life. Prenatal exposure to phthalates was associated with changes in BMI and head circumference during the first year of life in the Netherlands-- boys with lower phthalate exposures had a higher BMI than those more highly exposed, at 11 months of age (de Cock et al. 2014). Also in the Netherlands, maternal phthalic acid levels were associated with higher triglycerides in boys, and maternal phthalate levels were associated with lower glucose levels in boys (Sol et al. 2020a), and maternal phthalate acid levels were linked to higher body fat in children at age 10 (Sol et al. 2020b).
In Spain, prenatal phthalate exposure was associated with lower early weight gain in infancy and lower BMI at 4-7 years of age in boys, but with higher infant weight gain and childhood BMI in girls (Valvi et al. 2015). The same Spanish study, this time analyzing 27 different endocrine disrupting chemicals found that in utero levels of various persistent organic pollutants were associated with overweight/higher BMI at age 7, while other chemical levels (phthalates, flame retardants, arsenic, BPA, lead, and cadmium) were not associated (Agay-Shay et al. 2015).
In the U.S., levels of non-DEHP phthalates in the womb were associated with a lower BMI, smaller waist circumference, and lower fat mass in boys at age 5-7 (there was no association in girls, or with DEHP metabolite levels). This study was based on data from the Columbia Center for Children’s Environmental Health (CCCEH) study of African-American and Dominican women in New York City (Maresca et al. 2016). These authors also found epigenetic changes in the placenta that were associated with phthalate levels and may explain mechanisms behind associations (Adibi et al. 2017). Also in New York City, data from the The Mount Sinai Children’s Environmental Health Study showed that pre-natal phthalate levels were not associated with body fat in children at age 4-9, although high DEHP levels were associated with slightly lower fat mass at that age (Buckley et al. 2016a). For an article on this study, see Phthalates and Childhood Body Fat: Study Finds No Evidence of Obesogenicity, published in Environmental Health Perspectives (Nicole 2016).
A U.S. study, of data from 3 different cohorts, found that maternal levels of the phthalate metabolite MCPP was associated with overweight/obesity in children at 4-7 years of age. DEPH levels were associated with lower BMI in girls as well (Buckley et al. 2016b). Another study of three U.S. sites found that phthalate levels at age 6-8 were associated with gains in BMI and waist circumference at age 7-13. The associations were only found for low molecular weight phthalates (Deierlein et al. 2016). The TIDES study from 4 different US sites found that prenatal phthalate levels were associated with lower birthweight, and then higher BMI at age 3-4 (Ferguson et al. 2022).
The HOME study from Cincinnati, Ohio, found that early life exposure was generally not associated with signs of obesity at age 8 (Shoaff et al. 2017). A follow up found gestational and childhood exposure to some phthalate levels were linked to slightly lower weight or slightly increased lean mass at age 12 (Etzel et al. 2022a). This study also found that early life levels of MEP, MiBP, and MnBP were associated with lower LDL and HDL cholesterol levels at age 12 years, with lower LDL levels seen in females but not males. Higher phthalate levels during adolescence were associated with increased insulin resistance in those children (Etzel et al. 2022b).
In Colorado, gestational phthalate (and phenol) exposure was associated with lower infant weight and fat mass at birth and at 5 months in males (Stevens et al. 2023).
The U.S. Center of Health Assessment of Mothers and Children of Salinas (CHAMACOS) is a longitudinal birth cohort study examining the impact of pesticide and other environmental exposures on the health and development of Mexican-American children living in the Salinas Valley, an agricultural region in California. In this cohort, in utero exposure to some phthalates was associated with an increased risk of obesity or overweight at age 12 (Harley et al. 2017). Examined in more detail, the authors find different childhood BMI development patterns in relation to phthalate exposure levels, including a non-linear association between prenatal monoethyl phthalate urinary concentrations and BMI in children, which varies by sex (Heggeseth et al. 2019). In newborns, prenatal phthalate exposure levels were associated with epigenetic changes in genetic regions related to inflammation and endocrine function (as well as cancer and male fertility) (Solomon et al. 2017). Exposure to phthalates in pregnant women is associated with oxidative stress in these mothers (Holland et al. 2016), and with markers of oxidative stress and metabolic dysfunction in their children (Tran et al. 2017). In CHAMACOS, prenatal exposure to various phthalate metabolites and propylparaben were consistently associated with an increased BMI and overweight/obesity in childhood. Higher prenatal exposures to mixtures of chemicals also trended with greater childhood weight (Berger et al. 2021).
In Canada, first-trimester maternal levels of phthalates were associated with higher leptin levels in male infants-- leptin is a hormone that controls the amount of fat stored in the body. These babies will be followed to see if there are any later-life health effects associated with early phthalate exposure (Ashley-Martin et al. 2014).
A large European study found no association between prenatal or childhood phthalate exposure levels and childhood BMI (Vrijheid et al. 2020).
In Sweden, prenatal exposure to a mixture of EDCs (phthalates, other plasticizers, phenols, PAHs, pesticides, PFAS, organochlorine pesticides, and PCBs) was associated with lower BMI and overweight among girls, and there were non-significant associations among boys at age 5 1/2 (Svensson et al. 2023).
In Greece, prenatal phthalate exposure was not consistently associated with child weight-related measures. Exposure during childhood, however, was. Phthalate metabolite levels were associated with lower BMI in boys and higher BMI in girls; DEHP was associated with a lower waist circumference in boys and higher in girls; phthalate metabolite concentrations at age 4 were negatively associated with blood pressure; and MiBP was associated with higher total cholesterol levels (Vafeiadi et al. 2018).
The Early Life Exposure in Mexico to Environmental Toxicants (ELEMENT) study of pregnant women and their offspring in Mexico City has looked at phthalate exposures in the womb and later metabolism in the children, finding that early life exposure (from prenatal through puberty) to various phthalates were associated with aspects of metabolism in 8-14 year old children. The associations varied by sex, age, and stage of puberty. For example, exposure to MEP in the womb was associated with lower insulin secretion in boys at puberty and higher leptin levels in girls (Watkins et al. 2016). Exposure to MBzP in the womb was associated with a lower BMI in childhood, and childhood exposure to MEHP was associated with a lower waist circumference in childhood (Yang et al. 2017). Additional phthalates were associated with higher growth and BMI by age 14, in ways that varied by sex and by exposure timing (Yang et al. 2018). Early gestation MBP, MIBP, and MBzP were associated with higher BMI and other weight-related measures in girls, whereas second trimester and adolescent MBzP were associated with weight-related measures in boys in opposite directions (Bowman et al. 2019). Various phthalates levels (at puberty, but not in utero) were associated with lower cholesterol levels in these children (Perng et al. 2017).
The PROGRESS cohort, also in in Mexico City, found that individual phthalate levels were not associated with cholesterol levels in children at age 6, and that higher total phthalate levels were associated with lower triglycerides and "bad" cholesterol levels (Allison et al. 2020). Also in this cohort, prenatal concentrations of DEHP and DiNP metabolites were associated with increased weight gain trajectories during childhood (Kupsco et al. 2021). And in another study in Mexico, DEHP kevels during pregnancy were associated with significantly increased body fat percentage in childhood, mainly in boys (Montes et al. 2021).
In Korea, DEHP levels in newborns were associated with a higher body mass increase in the first three months after birth (Kim et al. 2016). Prenatal exposure to phthalates was associated with lower BMI and lower skeletal muscle in 6 year old Korean girls (Lee et al. 2019). In Japan, maternal phthalate levels were associated with cord blood leptin and adiponectin (a hormone that helps regulate glucose levels) as well as birth size (Minatoya et al. 2017). Another study from the same authors found maternal phthalate levels were associated with lower leptin levels in cord blood (Minatoya et al. 2018).
In China, the relationships between DEHP exposure in the womb and fetal/early childhood growth rates varied by the timing of exposure (which trimester) and the sex of the baby (Li et al. 2021). Also in China, in utero exposure to phthalates, including MEP and DEHP metabolites (MEHHP and MEOHP), especially during the third trimester, was associated with high BMI trajectories in girls in early childhood (Gao et al. 2022a). The same authors also found that prenatal phthalate mixtures were variously associated with cardio-metabolic risk scores in children; some increased risk, some decreased, varying by trimester (Gao et al. 2022b). They also found that children were more likely to be obese when they were exposed to higher levels of some phthalates in the womb (Gao et al. 2023). Also in China, exposure to various phthalates in the womb were variously associated with growth in the first two years of life (Yang et al. 2023).
In Australia, prenatal phthalate levels were associated with taller height (up to age 20), with some inconsistent associations with body fat measurements (Berman et al. 2021a). Another publication by the same authors with the same cohort (the Raine Study) found weak negative associations between prenatal exposure to some phthalate metabolites and change in height and weight during infancy, and weak positive associations between prenatal exposure to some of the high molecular weight phthalate metabolites and height during childhood (Berman et al. 2021b). The Raine Study also found that higher prenatal phthalate exposures to some phthalate metabolites was associated with some adverse diabetes/obesity related health effects through adolescence into adulthood, although mostly inconsistently. Some were consistent, however, including links to systolic blood pressure, fasting insulin, and glucose (Berman et al. 2022).
Epigenetic mechanisms may play a role in exposures during development; epigenetic changes in growth and metabolism-related genes in infants were associated with BPA and phthalate levels in cord blood of Michigan babies (Montrose et al. 2018).
Cross-Sectional Studies in Adults
Cross-sectional studies are studies that measure exposure and disease at one point in time. These provide weaker evidence than longitudinal studies, since the disease may potentially affect the exposure, and not vice versa.
U.S. adult women with higher levels of several phthalates had a higher risk of diabetes. Women with the highest levels of some phthalates had twice the risk of diabetes as those with the lowest levels (James-Todd et al. 2012). In an expansion of this study, some of the same researchers found that phthalate levels were associated with higher fasting blood glucose levels, fasting insulin levels, and increased insulin resistance. These associations were strongest in Mexican Americans and non-Hispanic Blacks, suggesting that these groups may be more vulnerable to phthalate exposures relating to diabetes (Huang et al. 2014). They also found that phthalate levels were associated with metabolic syndrome (the specific phthalate that was associated with metabolic syndrome varied, depending on sex and menopausal status) (James-Todd et al. 2016). Another study of U.S. adults also depended on sex and race and type of pthalate: In white women only, higher MCOP levels were associated with increased risk of metabolic syndrome while MEHP with a lower risk. In white men only, the sum of DEHP metabolites were associated with an increased risk, and in Black men only, MEP was linked to a lower risk (Ghosh et al. 2021). Using NHANES data, a study found that in U.S. women, exposure to certain phthalate metabolites was associated with obesity and metabolic syndrome, depending on menopausal status (Dubey et al. 2022). In U.S. adults (also NHANES), mixtures of phthalates were associated with increased insulin resistance (Chen et al. 2023).
A chemical mixture (nine common chemicals-- one phenol, two parabens, two chlorophenols and four phthalates) increased the risk of insulin resistance in US adults, with DEHP being the main culprit (Bai et al. 2022). In U.S. adults, higher levels of mono-ethyl phthalate (MEP), naphthalene metabolites, and a pattern of high exposure levels of other phthalates (MCOP, MCNP, and MCPP) were associated with an increased risk of obesity (Zhang et al. 2022).
In Swedish elderly people, three of four types of phthalate metabolites were associated with an increased prevalence of type 2 diabetes. The phthalate metabolites linked to diabetes included MMP, MiBP, and MEP, which are breakdown products of phthalates found in body care products. MiBP was related to poor insulin secretion, while MMP and MEP were related to insulin resistance. The phthalate metabolite MEHP, which is a breakdown product of the plasticizer DEHP, was not associated with diabetes (Lind et al. 2012). Phthalates activate certain hormone receptors called PPARs. PPARs are known to influence blood glucose levels, via insulin resistance, insulin secretion, and fat formation. Interestingly, pharmaceutical drugs that have the opposite effect on PPARs are used to treat type 2 diabetes, by decreasing insulin resistance (Lind et al. 2012). Another study of the elderly, this time in men from Australia, also found phthalate levels to be associated with obesity (Bai et al. 2015). And in Chinese elderly people with diabetes, phthalate levels were associated with higher levels of insulin resistance (Dong et al. 2018).
Phthalates have also been associated with diabetes in Mexican women. That study found that levels of three types of DEHP metabolites were higher in adult women with diabetes than those without diabetes. The results suggest that phthalate exposures may play a role in diabetes development (Svensson et al. 2011). In elderly Swedes, various phthalates were associated with fasting blood glucose levels, as well as cholesterol and blood pressure (Olsén et al. 2012). In Belgian adults with obesity, phthalate levels were linked to insulin resistance (Dirinck et al. 2015). While in Turkish adults, phthalate levels were strongly associated with BMI (Oktar et al. 2017). And in U.S. adults, certain phthalates were linked to high blood pressure, a component of metabolic syndrome (Shiue 2014a; Shiue 2014b). In Dutch adults, phthalate levels were associated with a higher BMI and waist circumference (van der Meer et al. 2020).
In the U.S., levels of several phthalate metabolites were associated with increased insulin resistance and abdominal obesity in men (Stahlhut et al. 2007). In another U.S. study, of people aged 6-80, various phthalate metabolites were associated with higher body mass index (BMI) and waist circumference in men aged 20-59. Effects in women were not as consistent. In some ages, exposures was associated with lower BMI (Hatch et al. 2008; Hatch et al. 2010). In a third U.S. study, a number of phthalates were associated with obesity in men and women, with differences depending on the type of phthalate, age, and sex (Buser et al. 2014). In a fourth U.S. study, certain phthalate metabolites were associated with an increased risk of overweight/obesity and BMI in black children, but not children of other ethnic groups (Trasande et al. 2013b). And a fifth study found that phthalate metabolite levels in U.S. women were associated with BMI, waist circumference, and cholesterol levels. The associations varied by metabolite. Women who had slower conversion of MEHP to its metabolite had both higher BMI and waist circumference (Yaghiyan et al. 2015). Compared to other phthalates and other chemicals, mono carboxyoctyl phthalate (MCOP), was one of the most important chemicals associated with obesity (Zhang et al. 2018). Thus the relationship between phthalates and obesity may depend on gender, age, race, type of phthalate, and metabolic rate of processing phthalates in the body. And some argue that according to their model, increased food intake can lead to both higher weight and higher phthalate levels, which might help explain some associations (Campbell et al. 2018). The relationship between DEHP and insulin resistance also appears to be affected by the levels of beta-carotene (an antioxidant) in blood; thus diet is also important and may help protect against the effects of phthalates (Li et al. 2019).
Canadian teens and adults without diabetes with higher phthalate levels had higher blood glucose levels, insulin levels, and insulin resistance (Dales et al. 2018).
In Slovakian hairdressers exposed to high occupational levels of phthalates, various phthalate levels were associated with BMI and fat mass (Kolena et al. 2017). Another study of Slovakians occupationally exposed to phthalates found that MEHP was associated with a lower BMI and other variables in females, but not in males (Petrovičová et al. 2016). Slovakian nurses exposed to phthalates had a higher risk of abdominal obesity (Kolena et al. 2022). In the Czech Republic, phthalate levels were higher in people with type 2 diabetes (but not associated with blood pressure or lipid/cholesterol levels) (Piecha et al. 2016). In Serbia, phthalate levels in men were associated with a variety of metabolic markers, including lower HDL levels (the "good" cholesterol), higher BMI, and higher triglycerides (Milošević et al. 2017). A larger study by these authors also found that various phthalates were differently associated with various measures of metabolism in different subgroups, including with higher glucose levels in people with type 2 diabetes (Milošević et al. 2019).
In Australian men, phthalate levels were associated with type 2 diabetes, high blood pressure, cardiovascular disease, and inflammation (Bai et al. 2017).
In Serbian women with polycystic ovary syndrome PCOS, phthalate levels were associated with BMI, waist circumference, fasting glucose, insulin resistance, LDL cholesterol, and triglyceride levels (Milankov et al. 2023).
In Taiwanese military personnel, higher daily intake of dimethyl phthalate (DMP) was associated with higher insulin resistance and metabolic syndrome. Higher daily intake of benzyl butyl phthalate (BBzP) was associated with an increased risk of abdominal obesity (Ko et al. 2019). Oxidative stress appears to be part of the reason that higher phthalate exposure is linked to higher insulin resistance in these soldiers (Hsia et al. 2022). Thyroid levels seem to also be involved in the associations between phthalates and insulin resistance (Huang et al. 2021). Also in Taiwan, in both adults and children, phthalate levels were associated with various measures of growth hormones (Huang et al. 2017). Higher concentrations of MEP metabolites were associated with increased odds of metabolic syndrome in Taiwanese men. Postmenopausal women with higher DEHP concentrations had more than nine-fold higher odds of metabolic syndrome compared with postmenopausal women with the lowest DEHP concentrations (Shih et al. 2022).
In China, numerous phthalate metabolites were associated with diabetes in males, as well as with high cholesterol levels in both sexes (Dong et al. 2017a). Another study from China (Shanghai), found that numerous phthalates were associated with obesity, especially central obesity, especially in women, and especially in women under 45 (Dong et al. 2017b). Exposure to phthalates was positively associated with type 2 diabetes, fasting glucose, and long-term blood glucose (HbA1c) levels in an additional Chinese study, and the associations differed based on sex, BMI, and age (Duan et al. 2019) (Metabolism may play a role in these associations (Duan et al. 2021)). Also in China, phthalate levels were associated with high blood pressure and higher total cholesterol levels (Zhang et al. 2018). In elderly Chinese people, higher levels of various phthalate metabolites were correlated with obesity, with variations by sex (Li et al. 2020).
Korean adults with diabetes had higher phthalate levels than people without diabetes (Nam et al. 2020). MEHHP phthalate levels were associated with a higher risk of metabolic syndrome as well (Shim et al. 2019). But phthalate levels were not associated with obesity however (Lim et al. 2020). Yet in a different study, MBzP was in fact associated with obesity in Korean adults (but phthalates were not associated with diabetes) (Lee et al. 2020).
In Korea, exposure to EDC mixtures (phthalates, phenols, parabens, and a pesticide) is associated with higher BMI in adults and adolescents (Kim et al. 2022).
These findings may depend on sex. In Korean women, MEHHP and DEHP levels were associated with an increased risk of obesity. Among men, MnBP levels were associated with a lower risk of obesity. Women over age 50 with higher levels of DEHP, DEHP metabolites, and MBzP, had a higher risk of obesity, while in men over 50 there were no significant associations between phthalate levels and obesity (Kang et al. 2019). In Korean women of reproductive age, DEHP metabolites and ethyl paraben were associated with increased adiponectin levels, and DEHP metabolites were also positively associated with fasting glucose levels. MMP, MiBP, and BPS levels were associated with higher insulin resistance, while propyl paraben levels were associated with less insulin resistance (Lee et al. 2019). In Taiwanese people aged 12-30, higher MEHP levels were associated with lower adiponectin levels, and epigenetics may play a role in this association (Lin et al. 2023).
Cross-Sectional Studies in Children
In U.S. adolescents, DEHP phthalate metabolite levels were associated with increased insulin resistance (Trasande et al. 2013a). DEHP is being replaced with DINP and DIDP. It turns out that metabolites of those replacements are also associated with insulin resistance in U.S. adolescents (they also confirmed the previous association with DEHP metabolites) (Attina and Trasande 2015). Some of the same authors also report that higher molecular weight phthalates (a category that includes DEHP, DINP, and DIDP) are associated with insulin resistance in Mexican American and Hispanic 10-13 year olds (Kataria et al. 2017). Also in U.S. adolescents, the phthalate metabolite MnBP and was associated with metabolic syndrome; some other associations varied by sex (Gaston and Tulve 2018).
In U.S. children and adolescents, of 9 chemicals studied using a few different statistical methods, MEP was one that was most strongly associated with an increased risk of obesity (Wu et al. 2020).
In Mexican adolescents, phthalate levels were linked to lipid levels (e.g., cholesterol) in males (Zamora et al. 2023).
In Chinese schoolchildren, levels of certain phthalates were associated with increased BMI or waist circumference (Wang et al. 2013). Another Chinese study found that levels of certain phthalates were associated with higher BMI and fat distribution in boys over 10, but lower fat distribution in girls under 10 (Zhang et al. 2014). A third found that phthalates were associated with various growth hormone levels in young Chinese children (Wu et al. 2017). A fourth found various associations between various phthalates and different measures of obesity/weight (Wu et al. 2018). A fifth found an association between MnBP levels and overweight/obesity (Xia et al. 2018). Another found phthalates linked to high blood pressure in children (Yao et al. 2020). Another, of Chinese children age 7-10, found that levels of monoethyl phthalate and monoisobutyl phthalate were associated with a large increased risk of abdominal obesity (Wang et al. 2022). In Chinese adolescents, higher DEHP metabolite levels were associated with worse cholesterol/triglyceride levels (Xu et al. 2023). In Chinese children, Diet and physical activity, but not phthalate metabolites, were associated with an increased risk of childhood obesity (Li et al. 2023).
In Korean girls, certain phthalates were associated with obesity (Choi et al. 2014), and phthalate levels were associated with higher LDL cholesterol levels in children and adolescents (Hyun Kim et al. 2018). The ratios of various DEHP metabolites was linked to BMI in Korean children as well (On et al. 2021). Korean children with obesity had higher levels of one type of phthalate but not others (Seo et al. 2022).
In Taiwanese children, levels of certain phthalates were associated with a higher BMI in boys, and others with a lower BMI in girls (Lien et al. 2018). In Taiwanese adolescents, phthalate levels were associated with abdominal obesity (Hou et al. 2015). Another study of Taiwanese adolescents and young adults found that phthalate levels were associated with insulin resistance (and lower testosterone levels) in the young adults, but not in the adolescents (Chen et al. 2017). Male Taiwanese children with higher phthalate levels have higher body weight, BMI, and body fat percentages. A epigenetic change was identified as a possible mechanism (Chang et al. 2020).
A Thai study did not find an association between metabolic markers and MBP or MMP phthalates in children/teens with obesity (Saengkaew et al. 2017). However another Thai study found that higher phthalate concentrations were associated with elevated total fat mass in children aged 6-13 (Nakaviroj et al. 2022).
In Iranian children and teens, almost all phthalates measured showed associations with BMI and waist circumference (Amin et al. 2018a), as well as cardiovascular risk factor and obesity (Amin et al. 2018b). Also in Iranian children and teens, phthalate levels were associated with metabolic problems no matter what their weight (Mansouri et al. 2019). And, in Iranian children and teens, concentrations of phthalate metabolites had a significant relationship with systolic blood pressure, fasting blood sugar, triglycerides, and insulin resistance (Hashemi et al. 2021).
In Denmark, phthalate levels in normal-weight teens and children were not associated with various measures of diabetes or metabolism (Carlsson et al. 2018).
Maternal exposure to phthalate metabolites has been associated with birth weight in infants. (Low/high birth weight is also associated with type 2 or 1 diabetes; see the Gestation and Birth page). A review finds that the literature is inconsistent, but more consistent when phthalates are measured more than once during pregnancy (Vrachnis et al. 2021).
Prenatal phthalate metabolite levels are associated with low birth weight in Chinese newborns (Song et al 2018; Zhang et al. 2009). In mothers from Greenland, Poland, and Ukraine, the metabolite MEHHP was associated with lower birth weight, but that the metabolite MOiNP was associated with higher birth weight (Lenters et al. 2016). In a small study from the Netherlands, higher maternal levels of the metabolite MECPP were associated with lower birth weight in boys, but MEHHP was associated with higher birth weight in boys (de Cock et al. 2016). In Germany, some phthalate levels were linked to lower birth weight in girls but not boys (Nidens et al. 2021).
Interestingly, the father's exposure to phthalates before conception might also be important for offspring health. Paternal preconception levels of DEHP were associated with lower birth weight in offspring conceived by IVF (Messerlain et al. 2017). Very few studies have looked at paternal exposures, so this will be an important area to pursue.
Laboratory Studies: Diabetes/Obesity
In animals, rats given the phthalate DEHP developed symptoms of diabetes, including higher blood sugar and lower insulin levels. The changes reversed when the exposure was removed (Gayathri et al. 2004). A study at the cellular level shows the direct adverse effect of DEHP on the gene expression relating to insulin and glucose, suggesting that DEHP exposure may have a negative influence on insulin signaling (how the body responds to insulin) (Rajesh and Balasubramanian, 2014). Short term treatment of rats with a number of different phthalates found that some of the phthalates (DEHP, MEHP, and MBeP) caused high blood glucose levels (Kwack et al. 2010). Rats treated with DEP had higher blood glucose levels than controls as well (Pereria and Rao, 2006). Mice genetically prone to heart disease developed high blood sugar and glucose intolerance when exposed to phthalates, although the symptoms resolved 4-12 weeks after exposure ended (Zhou et al. 2015).
Female obesity-resistant mice exposed to DEHP for 10 weeks gained weight, had increased fat mass, and had impaired insulin tolerance. It appears that DEHP affects the function of fatty tissue, but perhaps not whole-body glucose metabolism, because things like glucose tolerance, glucose levels, and insulin levels were not affected (Klöting et al. 2015). Male mice given DEHP for 5 weeks gained weight and also developed hypothyroidism (Lv et al. 2016). Adolescent rats exposed to DEHP developed higher fasting glucose levels, higher insulin levels, and insulin resistance (Xu et al. 2018). These authors also found that DEHP exposed rats had increased body weight, more fat cells, inflammation, and higher cholesterol levels (Zhou et al. 2018). DEHP also increases blood pressure in mice (Deng et al. 2019).
Adult rats given DEHP for a month developed high blood sugar, insulin resistance, and other changes associated with diabetes. Those given DEHP plus the antioxidant vitamins E and C, however, did not develop these symptoms of diabetes (Rajesh et al. 2013; Srinivasan et al. 2011). These vitamins essentially prevented diabetes in phthalate-exposed mice-- a sign of how nutrition and chemical exposures may interact to affect disease risk.
Rats exposed to DEHP had increased body weight, as well as higher lipid, insulin, and leptin levels (Jia et al. 2016). Other researchers have also found that DEHP leads to increased body weight in rats (Zhang et al. 2019a), which is worsened by a high-fat diet (Zhang et al. 2019b). The insulin resistance caused by DEHP is due to mechanisms involving PPARγ (Zhang et al. 2017). MEHP also appears to act on fat cells via mechanisms related to PPARγ (Chiang et al. 2017). DEHP also affects cholesterol levels in rats, and these changes were accompanied by epigenetic changes in the liver and fat tissue (Xu et al. 2020). DEHP increased total cholesterol levels in rats (Li et al. 2022). The metabolites of DEHP and its replacement DINCH (MEHP and MINCH) bind to PPARγ, which is involved in obesity, and scientists have figured out exactly how (Useini et al. 2023).
DEHP exacerbated type 2 diabetes in mice, by causing insulin resistance in the liver, and females were more susceptible (Ding et al. 2021). Mice with obesity treated with environmentally-relevant levels of DEHP exhibited higher glucose intolerance and insulin resistance than unexposed mice with obesity; the DEHP effects were not observed in lean mice (Hsu et al. 2021). Exposure to both DEHP and overfeeding decreased exercise performance in zebrafish, and DEHP affected metabolic gene expression in the gut and liver tissue (Buerger et al. 2022). Low dose DEHP increased fat accumulation both in control and high-fat diet fed mice, and accelerated weight gain without affecting food intake in high-fat diet fed mice (Zhang et al. 2023).
Chronic exposure to the phthalate DEP in diet -- at levels lower than the recommended tolerated dose -- causes insulin resistance in mice by disrupting the metabolic function of liver and fat tissue (Mondal and Mukherjee, 2020). DEHP also causes insulin resistance in mice (Wei et al. 2020).
The phthalate benzyl butyl phthalate (BBP), a common food packaging plasticizer, also disrupts metabolism and increases fat cell development (Yin et al. 2016). BBP increases fat cell development via epigenetic mechanisms (Zhang and Choudhury, 2017). In mice, BBP exposure produced a number of detrimental metabolic effects. Male mice exposed to moderate levels of BBP and a high-fat diet were especially affected, with significant increases in body weight and fat tissue (Zhang et al. 2020).
Low-dose exposure to the phthalate DBP leads to higher glucose levels, weight gain, and higher BMI in rats (Majeed et al. 2017). In mice, DBP exposure causes insulin resistance and impairs insulin secretion (Deng et al. 2018).
The phthalate MEHP was found to promote the formation of fat cells (DEHP is converted to the metabolite MEHP when ingested) (Feige et al. 2007). The phthalate DCHP has also been shown to promote the formation of fat cells through mechanisms involving the hormone glucocorticoid (Sargis et al. 2010). Disturbed glucocorticoid action is associated with a number of conditions, including type 2 diabetes, obesity, and autoimmune disease (Odermatt et al. 2006).
Desvergne et al. (2009) discuss potential mechanisms of phthalate action on obesity, via what they call "metabolic disruptors," a subset of endocrine disrupting chemicals (such as phthalates) that can alter metabolism. MEHP promotes fat formation through metabolic disruption and by affecting gene expression (Feige et al. 2007 Ellero-Simatos et al. 2011). Metabolic disruptors also may affect things like fat storage in the liver; phthalates have been found to increase fat content of the liver and liver inflammation, for example (Chen et al. 2016; Zhang et al. 2017; Zhang et al. 2023). Phthalates can interact with alcohol to affect the liver; DEHP alone or combined with ethanol caused lipid accumulation in the liver of mice (Li et al. 2020).
In female mice, chronic exposure to a phthalate mixture made white fat tissue more like brown fat tissue, and vice versa (Graceli et al. 2023).
Phthalates are present in house dust (along with other chemicals). Samples of house dust were found to cause metabolic effects such as triglyceride accumulation and fat cell promotion. One of the most potent of these chemicals was dibutyl phthalate (Kassotis et al. 2017).
Fish also show higher levels of glucose, triglycerides, food intake, and body weight when exposed to phthalates (Yuan et al. 2017). The phthalate DiDP increased total cholesterol and triglyceride levels in fish (Cocci et al. 2019). Exposure to the phthalates DEHP, DEP and DBP enhanced fat accumulation in the small freshwater crustacean Daphnia magna as well (Seyoum and Pradhan, 2019). The phthalate TBPH and its metabolite, TBMEHP, affect triglyceride and cholesterol levels in zebrafish (Guo et al. 2019). In the zebrafish liver, MBP caused fat accumulation and affected insulin levels (Zhang et al. 2021).
In laboratory experiments, phthalates altered seal blubber development and function, which could be important for the survival of seals and other marine mammals (Tranganida et al. 2022).
And, even fruit flies develop diabetes-like conditions when eating food contaminated with phthalates (DEHP), at levels comparable to human exposures (Cao et al. 2016); these fruit flies show that phthalates disrupt metabolism by controlling genes involved in glucose and lipid metabolism (Williams et al. 2016).
In the crustacean Daphnia magna, different phthalates each led to unique metabolic changes; low and high concentrations sometimes resulted in opposite effects. The findings show how traditional toxicity testing does not uncover metabolic effects like these (Oliveira Pereira et al. 2023).
Exposure During Development
A systematic review of 31 studies found that early life exposure of rodents to DEHP was significantly associated with increased fat weight, and non-significantly associated with increased body weight (Wassenaar and Legler, 2017).
When pregnant and lactating rats were given DEHP, their offspring developed abnormal beta cells, and alternations of the genes controlling beta cell function at the time of weaning. In adulthood, the female offspring had high blood glucose, impaired glucose tolerance and impaired insulin secretion. The adult males had increased insulin secretion. These results suggest that developmental exposure to phthalates can lead to beta cell dysfunction and glucose abnormalities, and is a potential risk factor for diabetes development (Lin et al. 2011).
When pregnant rats were exposed to DEHP, their offspring developed higher blood glucose, impaired glucose tolerance, and impaired insulin secretion/beta cell dysfunction later in life. They also showed epigenetic effects that changed the expression of genes relating to beta cell development and function (Rajesh and Balasubramanian, 2015). Male rats exposed to DEHP in the womb were smaller at birth but then caught up to controls and grew fatter as adults, and ended up with glucose intolerance as well (Strakovsky et al. 2015). Male offspring exposed to DEHP in the womb/early life had lower insulin levels than controls (Yang et al. 2018). Rats exposed to DEHP and DBP in the womb/early life had higher fasting glucose levels, and those exposed to DEHP also had lower insulin secretion (Venturelli et al. 2019). Studies with zebrafish also show that phthalates can affect beta cell development (Sant et al. 2016), and reduce the area of beta cells in the pancreas (Jacobs et al. 2018).
Female mice that were exposed to phthalates had higher body weight, more fatty tissue, and higher food intake than unexposed mice. Their offspring, only exposed during fetal development and while nursing, also exhibited similar metabolic changes, including higher body weight and more fatty tissue (Schmidt et al. 2012). For an article describing this study, see Long-term outcomes after phthalate exposure: food intake, weight gain, fat storage, and fertility in mice, published in Environmental Heath Perspectives (Holtcamp 2012). Another study also found that mice exposed to DEHP in the womb had higher food intake (Hayashi et al.2012).
Mice exposed to the phthalate MEHP in the womb had higher blood glucose levels, gained more weight, and had higher cholesterol levels later in life than unexposed mice (Hao et al. 2012). A similar study by the same authors found that another phthalate, DEHP, had the same effects (Hao et al. 2013). Male rats exposed to DEHP in the womb had fatty tissue inflammation as well as an increased immune response. DEHP may affect the development of pre-fat cells into fat cells, without affecting overall body weight (Campioli et al. 2014). Rats exposed in the womb to the phthalate DiBP had lower leptin and insulin levels later in life than controls, suggesting metabolic dysfunction (Boberg et al. 2008).
Mice exposed to DEHP in the womb had more obesity, higher blood pressure, and increased cholesterol levels (Lee et al. 2016). Other authors found that mice exposed to DEHP in the womb had higher glucose, insulin, leptin, and lipid levels, and more visceral fat (Gu et al. 2016). Developmental exposure to DEHP combined with a high fat diet in adulthood led to changes in metabolism in male offspring, and changes in the immune system in female offspring (Bastos Sales et al. 2018). Male rat offspring exposed to DEHP had high blood glucose and insulin levels, impaired glucose and insulin tolerance, and reduced levels of insulin receptors (Rajagopal et al. 2018). Prenatal exposure to low-doses of DEHP resulted in metabolic syndrome, including effects on fat, energy expenditure, and glucose metabolism, along with changes to the gut microbiome, while thiamine supplementation helped counteract these effects (Fan et al. 2019). Researchers are now figuring out the mechanisms by which phthalates have these types of effects (Hunt et al. 2017).
Rats exposed to low levels of DEHP only from nursing from their exposed mothers were found to have higher blood sugar and changes in insulin signaling later in life (Mangala Priya et al. 2014). Similarly, rats exposure to DEHP only in the womb were found to have higher blood sugar and insulin levels, and changes in insulin signalling later in life (Rajesh and Balasubramanian, 2014). Meanwhile, male rats exposed to DEHP only through their mother's milk had lower body weight but higher glucose levels (Parsanathan et al. 2018).
When pregnant mice were treated with the phthalate BBP, their offspring exercised less through early adulthood than untreated controls. Their body weight did not differ, however (Schmitt et al. 2016). In wild-type mice, in utero exposure to DEHP decreased glucose and leptin levels in offspring during the neonatal and weaning periods, which results in increased food consumption after weaning (Hayashi et al. 2019).
Prenatal exposure of mice to low-doses of dibutyl phthalate (DBP) promote obesity in offspring, along with glucose and cholesterol effects (Li et al. 2020). In female offspring rats, perinatal exposure to DBP caused increased weight and visceral adipose tissue and lower triglyceride levels, but no changes to fasting glucose, insulin resistance, fasting insulin, total cholesterol, or adiponectin levels (Zhou et al. 2022).
At levels that humans are exposed to, developmental DEHP exposure affected the metabolic system, liver, and thyroid in rats (Tassinari et al. 2020). Other studies also find mouse liver is affected by developmental exposure to phthalates (Neier et al. 2021).
Even fruit flies show effects from phthalate exposure. Long-term, high-dose DEHP exposure resulted in significant body weight change; dosing the father or mother resulted in increased or decreased body weight of the offspring respectively (Chen et al. 2019). Worms as well: early-life DEHP exposure resulted in an increased fat and triglyceride accumulation, mainly due to DEHP itself, not its metabolite MEHP. Developmental stage and exposure timing influence these effects, with chronic DEHP exposure being the most significant (How and Liao, 2022).
Phthalates and the Gut
A review finds that phthalates alter the gut microbiota, and that probiotics might be able to reduce the toxicity of phthalates (Goyal and Saravanan, 2023).
In specific studies, Long-term chronic DEHP exposure induces obesity through disruption of gut microbiota in mice (Su et al. 2021). In rats, exposure to phthalates during development negatively impacts the development of the small intestine (Setti Ahmed et al. 2018). In mice, phthalates damaged the small intestine (Yu et al. 2018) and affected the gut microbiota (Lei et al. 2019). In rats, DEHP induced cholesterol imbalance and disrupted gut microbiota diversity (Yu et al. 2020), and in mice, DEHP also disrupts gut microbiota (Chiu et al. 2021; Fu et al. 2021); mice with obesity were more susceptible to these effects than lean mice (Chai et al. 2023). Exposure to DEP (and other chemicals) during development affected the gut microbiota of rats in adolescence, although the changes diminished as the rats aged into adulthood (even when the exposure continued) (Hu et al. 2016). Exposure to MEHP during puberty, in combination with a high-fat diet, caused greater fat mass, higher total, HDL and LDL cholesterol, fat cell dysfunction, and a shift in gut microbiota composition in mice (Wang et al. 2018). The phthalate DiNP also affected the gut microbiota in mice (Chiu et al. 2022). The effects of phthalates on the gut are even seen in zebrafish (Buerger et al. 2019; Buerger et al. 2020) and quail (Yang et al. 2022). In zebrafish, for example, DEHP activated the gut immune system, affected gut microbiota, and caused changes linked to increased gut permeability (Adamovsky et al. 2020). Chronic exposure to DEHP at environmental levels significantly increased the body weight, length, and body mass index (BMI), especially in male zebrafish. It also disturbed bacterial composition and altered expressions of intestinal metabolites and immune and intestinal function-related genes (Jia et al. 2021). These changes in the intestine or gut are linked to diabetes (see the Diet and the Gut page). Interestingly, the effects of phthalates on lab animals can vary by strain/species, and one reason may be due to gut microbiota (Wang et al. 2020). In children, phthalate levels also increase the risk of gastrointestinal illnesses (Zhang et al. 2022), which are also linked to diabetes development (see the Viruses page).
Laboratory studies have established that epigenetic modifications caused by developmental exposure to environmental chemicals can induce alterations in gene expression that may persist throughout life. In the case of phthalates, some of these effects can be transferred from one generation to following generations (Singh and Li, 2012).
Another study of developmental exposure to mixtures of chemicals is even more alarming. It tested a mixture of BPA and two types of phthalates (DEHP and DBP), both found in plastics. Pregnant rats were exposed to this mixture, and outcomes evaluated in their offspring, for 3 generations. The third generation offspring (the exposed mothers' great-grandchildren), had higher rates of obesity (in addition to many other health issues). The mechanism involved not changes to DNA, but epigenetic changes that were passed down from one generation to the next (Manikkam et al. 2013). You can listen to a recording of a call with one of the authors of this study, Transgenerational Effects of Prenatal Exposure to Environmental Obesogens in Rodents, sponsored by the Collaborative on Health and the Environment (2013).
Paternal exposure-- i.e., exposing only the males before conception-- to dicyclohexyl phthalate (DCHP) led to insulin resistance and impaired insulin signaling in offspring mice. In the subsequent generation, the exposure caused glucose intolerance in females (i.e., the granddaughter mice) (Liu et al. 2023).
What are the effects of mixtures of chemicals? Very few studies have been done on chemicals in combination with one another, although that is how humans are exposed. One study exposed mice -- starting from before conception -- throughout life to very low doses (at levels thought to be "safe") of a combination of chemicals commonly found in food, including phthalates, BPA, dioxin, and PCBs, and fed them a high-fat diet. As adults, compared to unexposed controls, pollutant-exposed females developed impaired glucose tolerance, and males showed liver and cholesterol effects, as well as epigenetic changes (Naville et al. 2013). The same authors subsequently fed mice a high-fat, high-sugar diet, both with and without this same low-dose mixture of chemicals. This time, the chemical-exposed females showed improvement in glucose tolerance, inflammation, and insulin resistance at 7 weeks of age, but then worsening of these factors at 12 weeks of age. Thus the chemicals cause at first an apparent improvement, then a worsening as aging takes place (as compared to the mice fed the same diet but without chemicals) (Naville et al. 2015).
Another study of mixtures by the same authors shows that mice with lifelong exposure to low levels of this BPA, phthalates, dioxin and PCB mixture caused changes to metabolism (e.g., high triglycerides), which were slightly different than the effects of a high-fat, high-sugar diet (Labaronne et al. 2017). This exposure not only resulted in significant changes in triglyceride levels, but also on the expression levels of a variety of genes, including those relating to metabolism, especially under a standard diet. Depending on nutritional conditions and on the metabolic tissue considered, the impact of pollutants mimicked or opposed the effects of the high-fat high-sugar diet (Naville et al. 2019).
A mixture of BPA and the phthalate DBP caused changes related to metabolic disorders in developing embryos of zebrafish (Dong et al. 2018). Exposure during development to a mixture of phthalates, triclosan, and perfluorinated compounds (based on the levels of these compounds found in pregnant Swedish women) affected metabolic rate, increased the number of fat cells and fatty tissue young zebrafish fed a calorie-rich diet (Mentor et al. 2019). A mixture of DEHP, DBP and BPA was linked to markers of type 2 diabetes in rats, and probiotics reduced these effects (Baralić et al. 2021).
Rats exposed to BPA and DBP phthalate alone or in combination (at levels found in the environment) had islet cell immunoreactivity. The combined exposure led alpha and beta cell death, and BPA alone to alpha cell death (Morsi et al. 2022). Rats exposed to mixture DEHP and BPA during development developed insulin resistance and liver dysfunction (Wang et al. 2023).
Exposing placental cells to a mixture of phthalates at levels that humans are exposed to during pregnancy affected the PPARγ receptors, in an opposite manner in males vs females (Adibi et al. 2017). Developmental exposure of mice to a mixture of phthalates that humans are exposed to led to lower body weight in pups (Kougias et al. 2018). Developmental exposure to DINP led to increased body weight in mouse offspring, yet adding DEHP or DBP to the mixture did not increase the effect (Neier et al. 2018). Similarly, in female mice, developmental exposure to DEHP led to increased body fat, and developmental exposure to DINP led to impaired glucose tolerance. However, developmental exposure to mixtures of phthalates had few metabolic effects and were not associated with larger effects than single exposures (Neier et al. 2019). Thus the effects of phthalates mixtures may be complex.
In rodents, a mixture of BPA and phthalates acted synergistically in females and additively in males in the metabolic system (Tassinari et al. 2021).
In rats, probiotics almost completely eliminated the toxicity of a mixture of phthalates and BPA (Baralić et al. 2020).
In Vitro Studies of Cells
Beta Cells and the Pancreas
Phthalates can kill beta cells, and reduce insulin secretion from beta cells. Phthalates kill beta cells by increasing oxidative stress, and decreasing the ability of beta cells to protect themselves from this stress (Sun et al. 2015). A mixture of two phthalates (DEHP and DBP) kills beta cells, and the effects are significantly higher than the effects of each individual phthalate alone (Li et al. 2020). Beta cell dysfunction is linked to type 1 and type 2 diabetes development.
DEHP can kill beta cells in part via oxidative stress, and taurine, an amino acid, helps reverse this DEHP-induced oxidative stress (Li et al. 2019). MEHP can also cause beta cell apoptosis (programmed death) via oxidative stress, and a B vitamin is somewhat protective against this process (Shi et al. 2019). Both MBP and MEHP are moderate toxic to beta cells, also via oxidative stress (Karabulut and Barlas, 2021) or other mechanisms (Jiang et al. 2021).
At low doses, phthalate metabolites can also increase proliferation and insulin content of human beta cells (Güven et al. 2016). While this may sound positive, increasing insulin secretion can end up wearing out beta cells and leading to insulin resistance in the long run. The mechanisms by which phthalates decrease the viability beta cells are still being worked out, but appear to involve oxidative stress (She et al. 2017).
An interesting study found that BPA was more potent than phthalates in reducing beta cell function. Both BPA and the phthalate metabolites MiBP, MnBP, and MEHP reduced beta cell viability after 72 hours of exposure, with BPA most potent. Both BPA and the phthalate metabolites MEHP and MnBP increased insulin secretion after 2 hours of simultaneous exposure to the chemicals and glucose, with BPA again the most potent, followed by MEHP and MnBP. However, neither BPA nor the phthalates affected susceptibility to beta cell death. And, unlike other studies, low level exposures did not show effects (Weldingh et al. 2017).
In beta cells in vitro and in mice in vivo, microplastics and phthalates combined synergistically to cause beta cell death and oxidative stress (Wang et al. 2022).
Dibutyl phthalate (DBP) induced cell death and dysfunctional in insulin secreting cells through mechanisms involving oxidative stress (Yang et al. 2022).
DEHP can decrease glucagon secretion from pancreatic alpha cells (Al-Abdulla et al. 2023).
An in vitro (test tube) study of mixtures of phthalates, BPA, and organotins increased the development of fat cells from stem cells-- the effects of phthalates and organotins were more significant than of BPA (Biemann et al. 2014). Phthalates alone also promote the differentiation of fat cells from stem cells or pre-fat cells (Choi et al. 2021; Hao et al. 2021).
The phthalate MEHP disturbs the energy metabolism of fat cells (Chiang et al. 2016). A different lab showed that adult fat cells treated with MEHP led to inflammation and metabolic changes in the cells (Manteiga and Lee, 2017). MEHP disturbs energy metabolism in fat cells, increasing glucose uptake (Hsu et al. 2019). MEHP also causes triglyceride accumulation in pre-fat cells (Qi et al. 2020). A number of phthalates that are approved for use in food contact materials, at low levels of exposure, increased fat accumulation in fat cells (Pomatto et al. 2018). Researchers are figuring out the mechanisms involved in these effects (Hsu et al. 2020).
Phthalates found in PET plastics at levels found in the environment affected fat cell differentiation and inflammation (Molonia et al. 2022).
In bone marrow cells, DEHP and MEHP increased development of fat cells, and decreased development of bone cells. This finding may help explain why phthalate exposure is linked not only to obesity, but also lower bone mineral density (Chiu et al. 2018).
DEHP had a non-monotonic dose-response effect on fat cell formation (Fauziah et al. 2023).
The phthalate BBP induced epigenetic changes during fat cell differentiation (Meruvu et al. 2021). An extract from an orchid, Anoectochilus burmannicus ethanolic extract (ABE), was protective against the obesogenic effects of BBP (and BPA) in fat cells (Buacheen et al. 2023).
Muscle cells are also affected by DEHP and MEHP in relation to insulin signalling (which plays a role in insulin resistance) (Viswanathan et al. 2017). In liver cells, DEHP exerted toxic metabolic effects and increased insulin resistance through interfering with glucose metabolism. Cells already insulin resistant were more susceptible than normal liver cells (Ding et al. 2019).
MEHP caused fat accumulation in liver cells (Xu et al. 2020).
In 2002, an alternative chemical to phthalates was introduced to the market, known as DINCH (cyclohexane-1,2-dicarboxylic acid diisononyl ester). One of its metabolites, MINCH, has been found to facilitate the development of pre-fat cells into fat cells (Campioli et al. 2015). In rats, prenatal exposure to DINCH causes high blood glucose levels and impairs the liver as well (Campioli et al. 2017). In zebrafish, developmental exposure to DINCH affected genes related to fat and cholesterol as well (Saad et al. 2021).
Another phthalate replacement, diethylene glycol dibenzoate (DGB), also exhibits obesogenic properties in the lab (Santangeli et al. 2018). This pattern seems to be typical-- replacement chemicals may not be an improvement over the old chemicals. Meanwhile, the company that produces this chemical is publishing its own articles trying to refute these findings (Langsch et al. 2018). Also typical.
In newborn mice, the phthalate DINP, an alternative chemical to DEHP, along with DEHP, caused changes total fatty acid composition in blood, heart, and fatty tissues, although each chemical had different specific effects (Huang et al. 2019). DINP also promoted fat cell development (Zhang et al. 2019). After postnatal exposure, DEHP induced fewer metabolic changes in the liver of mouse pups as compared to DINP, which questions the suitability of DINP as a safe DEHP substitute (Yang et al. 2020). Numerous DEHP and substitutes metabolites enhanced fat cell differentiation, and affected the functionality of mature fat cells similar to effects of a high-fat diet (Schaffert et al. 2022).
Another alternative chemical, acetyl triethyl citrate (ATEC), a DEHP substitute, is used as a plasticizer in cosmetics and nail products. Mice exposed to DEHP or ATEC for 5 days had increased blood glucose levels, and a week after the exposure was removed, glucose levels returned to normal in DEHP-treated mice, but remained high in ATEC-treated mice (Lee et al. 2019). Thus the substitute may be even worse than the original. Wonderful. A similar alternative chemical, acetyl tributyl citrate (ATBC), increased body weight gain, body fat content, and fat cell size, and caused fatty liver at low exposure levels in mice (Zhang et al. 2023).
Type 1 Diabetes and Autoimmunity
The first human study of phthalates and type 1 diabetes found higher levels of DiBP phthalate metabolites in children with new-onset Portuguese type 1 diabetes (although not statistically significantly higher) (Castro-Correia et al. 2018).
A cross-sectional study of Boston women found that while phthalate levels were associated with poor thyroid function, they were not associated with autoimmunity (Souter et al. 2020).
In children with type 1 diabetes, levels of some phthalate metabolites (and a PCB) were associated with higher long-term blood glucose levels (HbA1c), and levels of a phthalate (and PFHxS, BPF, and a PCB) were linked to thyroid hormone levels (Dufour et al. 2023).
In non-obese diabetic (NOD) mice, an animal model of type 1 diabetes, BPA, but not a mixture of BPA and phthalates, or phthalates alone, accelerated diabetes development. Phthalates in fact seemed to dampen some of the diabetes-related effects of BPA (Bodin et al. 2015).
A review finds that phthalates affect and disrupt the immune system (Palacios-Arreola et al. 2021). Laboratory studies show how phthalates can affect the immune system, e.g., the secretion of inflammatory immune cells (Hansen et al. 2015). In a series of three studies, researchers examined the effects of phthalates on autoimmunity in mice. They found that after exposure to phthalates, different types of mice developed autoantibodies. But, only the autoimmune-prone mice went on to develop disease. They conclude that phthalates seem to be harmful only to susceptible strains of mice, while other strains are protected (Lim and Ghosh 2003; Lim and Ghosh 2004; Lim and Ghosh 2005). A study mentioned above found that male rats exposed to DEHP in the womb had an increased immune response, as well as chronic, low-grade systemic inflammation (Campioli et al. 2014). In fact, phthalate exposure in the womb caused epigenetic changes in adult male offspring in an area of genes that control the immune response, in rodents (Martinez-Arguelles and Papadopoulos, 2015).
Male rats exposed to MEHP or MBP had lower pancreas weights, higher glucose and triglyceride levels, and lower insulin levels, but did not have islet autoimmunity (Karabulut and Barlas, 2023).
For the effects of phthalates on beta cells, which are also significant for type 1 diabetes, see the type 2 diabetes and laboratory studies sections above.
Phthalate Levels Are Associated With Low Vitamin D Levels
In U.S. pregnant women, higher levels of both phthalates and BPA were associated with an increased risk of vitamin D deficiency. In these graphs you can see as chemical levels increase, vitamin D levels decrease.
Source: Johns et al. 2017, EHP.
Phthalates and Other Environmental Factors
In U.S. adults, phthalate levels are also linked to lower vitamin D levels (Johns et al. 2016), which may play a role in diabetes development (see the Vitamin D Deficiency page). These authors also found that phthalates were associated with vitamin D deficiency in pregnant U.S. women (Johns et al. 2017).
In infants, phthalate levels were linked to change in the gut microbiota, which may affect the immune system later in life (Yang et al. 2019); these changes are also linked to type 1 diabetes, as described on the Diet and the Gut page. Mice exposed to DEHP-contaminated microplastics had significantly increased intestinal permeability and intestinal inflammation, and alterations in gut microbiota composition, especially in bacteria related to energy metabolism and immune function. Also, 703 genes were differentially regulated and these genes are involved in oxidative stress, immune response, and metabolism (Deng et al. 2020). In mice, exposure to both low and high doses of DBP led to increased body weight and higher total cholesterol levels. DBP exposure also decreased mucus secretion, disturbed gut microbiota homeostasis, caused inflammation in the gut and liver, impaired intestinal barrier function, and induced liver lipid metabolism disorder (Xiong et al. 2020). These types of changes in intestinal permeability and inflammation are also linked to type 1 diabetes.
It is also interesting that levels of the phthalate DnBP is higher in Finland that in other European countries or the U.S. (Porras et al. 2020), since Finland has the highest incidence rates of type 1 diabetes in the world, and no one knows why.
A review suggests that weight gain, insulin resistance and pancreatic beta-cell dysfunction in pregnancy induced by phthalates may potentially play a role in the development of gestational diabetes (Filardi et al. 2020). Another review finds no consistent evidence for associations between phthalate exposure and "gestational metabolic syndrome," whatever that is (Gao et al. 2021).
In Canada, there was no association between first trimester levels of phthalates and gestational diabetes (although the sutdy did find an association with arsenic) (Shapiro et al. 2015). U.S. women with higher MBP and MIBP phthalate levels in their urine during early pregnancy actually had lower blood glucose levels when screened for gestational diabetes (Robledo et al. 2015). Similarly, Mexican women with gestational diabetes had lower levels of MEHP than those without diabetes (Martínez-Ibarra et al. 2019).
However, in Boston women, exposure to MEP, a metabolite of the parent compound DEP, is associated with excessive gestational weight gain and impaired glucose tolerance during pregnancy. But higher DEHP was associated with a lower risk of impaired glucose tolerance (James-Todd et al. 2016). These authors also found that certain phthalates were associated with higher early gestational weight gain (Bellavia et al. 2017). They also found that among women at a fertility clinic, the phthalate metabolites MEP and MiBP were associated with higher pregnancy glucose levels (James-Todd et al. 2018), but that although higher MEP was associated with higher glucose levels in mothers, phthalate levels were not related to higher birth weight (Noor et al. 2019). They also found that gestational weight gain was higher in pregnant women exposed to higher phthalate levels, especially in the first trimester (Tyagi et al. 2020). Another Boston study found that first trimester MBP, MCNP and MCPP were associated with lower glucose intolerance. In the second trimester, MCNP and MCPP were still associated with lower glucose intolerance, but MiBP and MHBP were associated with a higher risk of impaired glucose tolerance. For mixtures, second trimester dibutyl phthalate metabolites mixtures were associated with increased impaired glucose tolerance (James-Todd et al. 2022). Also in Boston, maternal levels of MCPP and MBP were associated with higher gestational weight gain in women with obesity; MBP showed a non-linear relationship (Boyer et al. 2023).
Another U.S. study found MnBP/MIBP levels in women with gestational diabetes (Adibi et al. 2017). In women without gestational diabetes, some phthalate levels were associated with higher post-meal glucose levels (Fisher et al. 2018). Also in the U.S., women with higher MEP levels had a higher risk of gestational diabetes. Additional phthalate metabolites were linked to a higher risk of glucose intolerance, with possible stronger associations in Asian Americans (Shaffer et al. 2019).
Phthalate levels were associated with cholesterol/triglyceride levels in U.S. pregnant women attending a fertility clinic in Massachusetts (Mínguez-Alarcón et al. 2022).
In fact a study from China did find that the associations depended on the type of phthalate. They found that first-trimester levels of MMP, MEP, MBP, MBzP and MEHHP were associated with higher fasting blood glucose levels in the third trimester, while MEHP and MEOHP levels were associated with lower glucose levels (Zhang et al. 2017). These results are different than the others' results, so more work to figure out what is going on is necessary. Also in China, higher MiBP, MnBP and MEHP levels in meconium were positively associated with gestational diabetes in mothers with male newborns (Guo et al. 2020), and exposure to higher levels of MiBP were related to increased blood pressure during pregnancy in pregnant women with male fetuses (Han et al. 2019). So the sex of the baby may make a difference.
In Chinese pregnant women, exposure to various individual phthalates or phthalate metabolites during the first trimester of pregnancy elevated blood pressure and fasting blood glucose levels in the third trimester and body weight gain throughout pregnancy. However, some phthalate metabolites had the opposite effect as the original phthalates. Higher exposure to the overall phthalate mixture in the first trimester was associated with an increased risk of gestational diabetes, higher weight gain during pregnancy, higher fasting blood glucose levels, and higher blood pressure as well (Gao et al. 2021). Chinese women with gestational diabetes had higher levels of MEHP in their urine, and the dose-response depended on the age of the women (Liang et al. 2022). Another study from China found that mono butyl phthalate (MBP) and mono isobutyl phthalate (MiBP) levels in blood were associated with an increased risk of both gestational diabetes and with higher 2-hour blood glucose levels (Wang et al. 2022). In rural China, levels of numerous phthalate metabolites were associated with an increased risk of developing gestational diabetes (Chen et al. 2022).
In pregnant California Latina farmworkers, higher phthalate levels were linked with markers of inflammation and cholesterol metabolism (Zhou et al. 2018). Also in these women (from the CHAMACOS cohort), MEP concentrations were associated with an increased odds of excessive gestational weight gain, but there were no associations between any phthalate metabolite and any maternal glucose-related health effect (Zukin et al. 2021).
In Europe, higher phthalate levels have been associated with lower blood pressure in pregnant women (Warembourg et al. 2018).
In a large population-based birth study from the Netherlands, early and mid-pregnancy phthalate exposure levels were associated with increased maternal weight gain 6 years after childbirth, particularly among women with overweight/obesity (Philips et al. 2020).
In Mexican women, increased levels of the phthalate metabolite MCPP during pregnancy were associated with higher weight gain, and the phthalate metabolite MBzP with lower weight gain, in the decade following pregnancy (the ELEMENT study) (Rodríguez-Carmona et al. 2018). The ELEMENT study also found that women with higher exposure to phthalates gained less weight during pregnancy, but then had slower weight loss in the year after childbirth (Perng et al. 2020).
In Mexican women in the PROGRESS study, higher levels of a mixture of phthalates during pregnancy were associated with higher levels of glucose, insulin, insulin resistance, and HbA1c 4-8 years post-delivery. The phthalates mixture was associated with lower HDL and higher triglyceride levels (Wu et al. 2021). This study also found that phthalate exposure levels in pregnant women were associated with lower gestational weight gain and higher long-term weight gain (6-7 years postpartum) (Deierlein et al. 2022).
In rats, di-n-butyl phthalate (DBP) aggravates the progression of gestational diabetes by causing a decline in beta cell viability (Chen et al. 2020).
Some authors used publicly available databases to create a computational adverse outcome pathway (cAOP) connecting phthalates to gestational diabetes, in other words, they found known mechanisms by which phthalates could contribute to gestational diabetes (Zhang et al. 2022).
Diabetes Management and Complications
A U.S. cross-sectional study found that phthalate levels were associated with retinopathy in people with type 2 diabetes (Mamtani et al. 2016). A study from China found that phthalates were associated with oxidative stress and inflammation in people with type 2 diabetes. These factors play a role in the development of complications from diabetes (Duan et al. 2017). In Italian people with type 2 diabetes, phthalate levels were associated with worse albuminuria, a kidney complication of diabetes, as well as with cardiovascular events (Mengozzi et al. 2018). Additional studies have also found associations between markers of kidney dysfunction and phthalate levels in people without diabetes (Chang et al. 2019; Chen et al. 2021; Chen et al. 2020; Chen et al. 2019; Kang et al. 2019; Lim and Yoon, 2019). Phthalate levels are higher in people undergoing kidney dialysis (presumably because they leach from the plastic dialysis equipment into the blood). These phthalates can also interfere with the protective effect of statins (Guo et al. 2020).
In the U.S., Phthalate levels were associated with an increased risk of diabetes, and in people with diabetes with an increased risk of mortality and cardiovascular mortality (Wang et al. 2023).
Phthalate exposure was positively associated with cardiovascular disease in Chinese adults with type 2 diabetes, especially in those currently smoking, with poor cholesterol levels, and who are not using statins (Zhang et al. 2021).
A small pilot study of Italians with type 2 diabetes found that those with higher phthalate exposures (both individually and mixtures) had higher long-term average blood glucose levels (HbA1c) (Mengozzi et al. 2022).
Phthalate levels have also been associated with the risk of heart disease in people who do not necessarily have diabetes (Su et al. 2019; Wiberg et al. 2014), and other factors related to cardiovascular health-- even in adolescents (Su et al. 2019). Phthalate levels are also associated with high cholesterol and high blood pressure (Olsén et al. 2012), including higher blood pressure during pregnancy (Werner et al. 2015). Phthalates, as well as phthalate replacement chemicals, were associated with higher blood pressure in U.S. children as well (Trasande and Attina 2015; Trasande et al. 2013). (Those studies were not done in people with diabetes). Reviews find that phthalate exposure may be associated with high blood pressure in adults (Lu et al. 2018) and with cardiovascular disease (Fu et al. 2020).
In cross-sectional studies, higher levels of some phthalates are associated with an increased prevalence of non-alcoholic fatty liver disease (NAFLD) in Korean (Yang et al. 2021) and U.S. (Cai et al. 2021; Chen et al. 2022; He et al. 2023) adults.
In Chinese people with type 2 diabetes, some phthalate metabolites associated with higher or lower thyroid hormone levels, but not with thyroid autoimmunity (Chen et al . 2021).
In animals, phthalate exposure accelerates atherosclerosis and interferes with cholesterol levels as well (Zhao et al. 2016). Phthalates also affect heart rate variability and other factors linked to cardiovascular problems (Amara et al. 2019; Jaimes et al. 2017). Phthalate exposure is linked to the development of NAFLD in laboratory studies as well (Bai et al. 2019; Huff et al. 2018; Zhang et al. 2021). Perinatal exposure to DEHP induced triglyceride accumulation in the rat liver (An et al. 2021). Lycopene, found in tomatoes and used as a dietary supplement, prevents DEHP-induced fatty liver in mice (Zhao et al. 2020). Developmental exposure to phthalates also increases blood pressure in rat offspring (Mariana et al. 2018).
Mice with diabetes are more susceptible to the cardiovascular, liver, and kidney effects of phthalates than mice without diabetes (Ding et al. 2019). Mice with diabetes are also more sensitive to the neurological effects of phthalates than mice without diabetes (Feng et al. 2020).
DEHP exacerbates diabetes-induced kidney injury in mice (Ding et al. 2023).
Maternal exposure to DEHP caused epigenetic changes in the liver of mice for 3 subsequent generations (Wen et al. 2020).
Removing Phthalates from the Body